This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Anne-Mette Lilleøre: Innovator in Pharmaceutical Composition
Introduction
Anne-Mette Lilleøre is a prominent inventor based in Charlottenlund, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations of peptides. Her work is crucial in advancing medical treatments and improving patient outcomes.
Latest Patents
Anne-Mette Lilleøre holds a patent for "Stable pharmaceutical composition comprising insulinotropic peptide." This innovative formulation is designed to enhance the stability and efficacy of peptide-based medications. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Lilleøre is associated with Novo Nordisk A/S, a leading global healthcare company known for its focus on diabetes care and other chronic conditions. Her role at Novo Nordisk has allowed her to work on groundbreaking research and development projects that aim to improve therapeutic options for patients.
Collaborations
Throughout her career, Anne-Mette Lilleøre has collaborated with esteemed colleagues, including Svend Ludvigsen and Morten Schlein. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Anne-Mette Lilleøre's contributions to the pharmaceutical industry exemplify her dedication to improving healthcare through innovative solutions. Her work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile